In This Section

AACR Award for Outstanding Achievement in Chemistry in Cancer Research

Nomination StatusClosed
Nomination Deadline

The AACR and its Chemistry in Cancer Research Working Group established this award in 2007, through the support of GlaxoSmithKline, to recognize the importance of chemistry to advancements in cancer research.

The award is intended to recognize outstanding, novel, and significant chemistry research, which has led to important contributions in basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer. Such research may include, but is not limited to, chemical aspects of carcinogenesis; chemical biology; drug discovery and design; imaging agents and radiotherapeutics; metabolomics and mass spectrometry; proteomics; and structural biology.

The award recipient will receive an honorarium and present an award lecture during the AACR Annual Meeting 2021.

Eligibility Criteria
  • Cancer researchers affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry, or government.

  • The award will be presented to an individual investigator. Two or more individuals may be selected to share the award in the event that their investigations are closely related in subject matter and have resulted in work worthy of an award.

  • Institutions and/or organizations are not eligible to receive the award.

  • Prior recipients of the AACR Bruce F. Cain Memorial Award are not eligible to be nominated for research previously recognized by the AACR Bruce F. Cain Memorial Award.

Contact Information

Michael J. Powell, PhD

Office: 215-440-9373

Fax: 215-446-7295

Email: [email protected]


Nomination Criteria


Nominations may be submitted by any individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Self-nominations are prohibited.

Nominators must maintain strict confidentiality of their nominations and all nominations must be submitted electronically. Paper nominations will not be accepted.

See the Program Guidelines and Nomination Instructions for complete details.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates who may be nominated by any individual scientist. There is no restriction on the number of nominators who may write nomination letters or who may sign a single nomination letter on behalf of a candidate.

If two or more candidates are nominated to share the award, a curriculum vitae and full publication history for all candidates must be submitted along with a combined letter of recommendation that fulfills the above criteria and clearly outlines how the work of the individuals is related and is worthy of the award.

Selection Process

Eligible nominees will be considered by an Award Selection Committee composed of an international cohort of cancer research experts appointed by the AACR president. After Award Committee deliberations, primary and alternate award recipient recommendations will be relayed to the AACR Executive Committee for formal ratification.

Selection of the award recipient shall be made on the basis of the candidate's scientific accomplishments without regard to race, gender, nationality, geographic location, or religious or political views.